We recently found that normal human epidermis produces relatively high
amounts of hepoxilins and trioxilins in vitro. Therefore, the aim of
this study was to demonstrate the presence of these compounds in psori
atic lesions. Extracts front scales of patients with chronic stable pl
aque psoriasis were analyzed by a combination of high performance liqu
id chromatography and gas chromatography-mass spectrometry techniques,
We found that the levels of hepoxilin B-3 were more than 16-fold high
er in psoriatic scales than in normal epidermis (3.2 +/- 2.3 and < 0.2
ng per mg, respectively), whereas hepoxilin A(3) was not detected in
ally sample, Trioxilins were semiquantitated and referred to 12-hydrox
yeicosatetraenoic acid, ratios of trioxilins A(3) and B-3 12-hydroxyei
cosatetraenoic acid in psoriatic lesions were 0.65 +/- 0.23 and 0.32 /- 0.28, respectively, and they were not detected in normal epidermis,
The presence of a great amount of trioxilin A(3) strongly suggests th
at hepoxilin A(3) was present in psoriatic lesions and it was totally
degraded to trioxilin A(3), during the analysis procedure, Our results
demonstrate that hepoxilins and trioxilins are produced by human skin
in vivo and that the levels of these compounds are increased in psori
asis, The reported biologic activities of hepoxilins indicate that the
y could amplify and maintain the inflammatory response, Our results re
inforce the idea that these compounds could play a role as mediators i
n the inflammatory response in skin, particularly in psoriasis.